re: patent fight and competition. From what I have read the Ventra Assist is a superior product to Incor and should have little problem becoming the first line treatment for critically ill patients in Europe from the end of 2005....
I bet the sceptics used to talk about competition for COH as well.
- Forums
- ASX - By Stock
- VCR
- next fall will be to 90 cents
VCR
ventracor limited
next fall will be to 90 cents, page-11
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)